Playboy Enterprises ( PLA) missed Wall Street's fourth-quarter earnings estimates, but the publishing concern's shares rose after it provided an upbeat forecast for fiscal-year earnings. The company, which produces Playboy magazine, said it earned $4.6 million, or 14 cents a share, in the fourth quarter, down from $14.5 million, or 43 cents a share, a year ago. Revenue rose 2% to $91 million. Analysts were looking for earnings of 18 cents and revenue of $90.5 million. For the full year, even after stock-option expenses of 10 cents a share, Playboy projected earnings of 67 cents to 70 cents a share. The consensus forecast is a profit of 67 cents. Shares of Playboy were up 91 cents, or 6.5%, to $14.91. China Finance Online ( JRJC) was sinking a day after the company said fourth-quarter revenue fell 8% from last year to $1.9 million while earnings slid 43% to $1.06 million. Earnings per American depositary share dropped to 5 cents from 9 cents in the same period a year ago, the provider of online financial information said. Following the report, Jefferies & Co. downgraded the stock to underperform from hold. China Finance was losing $1.59, or 20.2%, to $6.30. Genesee & Wyoming ( GWR) saw its shares jump 12% after its fourth-quarter earnings rose to $10.8 million, or 39 cents a share, from $7.2 million and 26 cents a share in the year-ago period. Revenue climbed to $103.3 million in the fourth quarter from $80.1 million last year, the freight-railroad operator said. Genesee recorded items that together reduced its earnings in the most recent quarter by about 13 cents. Analysts expected a profit of 42 cents in the quarter, excluding items. Additionally, the company's board approved a 3-for-2 split of its Class A and Class B common stock. Shares of Genesee were up $4.89 to $43.63.
PolyOne ( POL), a distributor of plastics and resins, was higher after it named Stephen D. Newlin chairman, president and chief executive, effective Feb. 21. William F. Patient, who has been serving as CEO, will move into the newly created position of lead director of the board. Patient agreed to take on the duties of CEO when Thomas A. Waltermire stepped down as president and CEO last October. Shares of PolyOne gained 63 cents, or 7.6%, to $8.88. Escalon Medical ( ESMC) was dropping after its second-quarter loss widened sharply compared with the same period a year earlier. For the most recent quarter, the company lost $982,000, or 16 cents a share, vs. a loss of $423,000, or 7 cents a share, a year ago. Revenue rose to $7.3 million from $6.3 million in the prior year. Shares of Escalon, a marketer of diagnostic and surgical products, fell 55 cents, or 9.9%, to $5.03.